首页> 美国卫生研究院文献>Aging and Disease >Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population
【2h】

Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population

机译:老年人群的免疫衰老和接种流感疫苗的挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Influenza is an important contributor to morbidity and mortality worldwide. Accumulation of genetic mutations termed antigenic drift, allows influenza viruses to inflict yearly epidemics that may result in 250,000 to 500,000 deaths annually. Over 90% of influenza-related deaths occur in the older adult population. This is at least in part a result of increasing dysregulation of the immune system with age, termed immunosenescence. This dysregulation results in reduced capacity to cope with infections and decreased responsiveness to vaccination. The older adult population is in dire need of improved vaccines capable of eliciting protective responses in the face of a waning immune system. This review focuses on the status of immunity, responses to influenza vaccination, and strategies that are currently being explored to elicit enhanced immune responses in this high risk population.
机译:流感是全世界发病率和死亡率的重要因素。称为抗原漂移的遗传突变的积累,使流感病毒每年都可流行一次,每年可能导致25万至500,000人死亡。超过90%的与流感有关的死亡发生在老年人口中。这至少部分是由于随着年龄的增长,免疫系统失调增加的结果,这种现象被称为免疫衰老。这种失调导致应付感染的能力降低和对疫苗接种的反应性降低。老年人迫切需要能够在免疫系统减弱的情况下引起保护性反应的改良疫苗。这篇综述着重于免疫状态,对流感疫苗的反应以及目前正在探索的在这种高风险人群中引发增强免疫反应的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号